Advancements in Cyclodextrin Complexes with Bioactive Secondary Metabolites and Their Pharmaceutical Applications DOI Creative Commons
Oana Elena Nicolaescu, Cătălina Ionescu, Adriana Samide

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(4), С. 506 - 506

Опубликована: Апрель 11, 2025

Cyclodextrins (CDs) have largely been investigated during the last decades for their outstanding properties, such as biocompatibility and biodegradability, with wide applications in pharmaceutical field, among which formation of inclusion complexes (ICs) natural or synthetic lipophilic compounds. This review prioritizes research recent years (2022–2025), being focused on (1) systematization ICs based structure secondary metabolite, namely (i) polyphenols (PPs), (ii) terpenes terpenoids (TTs), (iii) alkaloids (Alks); (2) each type complex, following aspects discussed: benefits complexation, composite materials, vitro/in vivo theoretical studies; (3) pharmacokinetics pharmacodynamics, risks, limitations, perspectives cyclodextrin metabolites.

Язык: Английский

Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics DOI Creative Commons
Oana Elena Nicolaescu,

Ionela Belu,

Andreea Gabriela Mocanu

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 288 - 288

Опубликована: Фев. 22, 2025

Cyclodextrins (CDs) have revolutionized the pharmaceutical industry with their ability to enhance stability, solubility, and bioavailability of a wide range active substances. These cyclic oligosaccharides, unique hydrophilic exterior hydrophobic cavity, form inclusion complexes poorly soluble drugs, improving pharmacokinetic profiles therapeutic efficacy. This review explores multifaceted roles cyclodextrins in formulations, ranging from oral, ophthalmic, parenteral, topical applications emerging use targeted therapies, gene delivery, treatment neurodegenerative, cardiovascular, infectious diseases. not only improve drug solubility controlled release but also reduce toxicity side effects, leading safer more effective treatments. Recent advancements, such as cyclodextrin-based nanoparticles, offer promising pathways for cancer therapy, chronic disease management, personalized medicine. As research continues, remain at forefront innovation delivery systems, ensuring better patient outcomes expanding possibilities modern therapeutics.

Язык: Английский

Процитировано

5

Ashwagandha: Optimizing the Extraction and Electrospun Nanofiber Production DOI Creative Commons

Maciej Jaskólski,

Magdalena Paczkowska-Walendowska, Andrzej Miklaszewski

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(1), С. 61 - 61

Опубликована: Янв. 5, 2025

Background/Objectives: This study explores the development of electrospun nanofibers incorporating bioactive compounds from Withania somnifera (Ashwagandha) root extract, focusing on optimizing extraction conditions and nanofiber composition to maximize biological activity application potential. Methods: Using Design Experiment (DoE) approach, optimal parameters were identified as 80% methanol, 70 °C, 60 min, yielding high levels phenolic antioxidant activity. Methanol concentration emerged critical factor influencing phytochemical properties. Electrospinning technology was employed produce using polyvinylpyrrolidone (PVP) hydroxypropyl-β-cyclodextrin (HPβCD) carriers, ensuring encapsulation, stabilization, an enhanced bioavailability active compounds. Results: Nanofibers demonstrated a surface-to-volume ratio, rapid dissolution, significant mucoadhesive properties, making them suitable for oral mucosal applications. The determined be 2.5 mL 25% PVP, extract-to-HPβCD ratio 1:0.6. Statistical modeling confirmed that electrospinning process did not compromise or anti-inflammatory properties with extract content being primary determinant Conclusions: These findings highlight potential integrating advanced techniques nanotechnology develop innovative delivery systems traditional herbal remedies. developed offer promising applications in pharmaceuticals, cosmetics, functional foods, paving way scalable efficient utilization Ashwagandha bioactives.

Язык: Английский

Процитировано

0

Comparative Analysis of γ-Cyclodextrin, Perilla Oil, and Their Inclusion Complexes on Liver Injury and Dyslipidemia Associated with Elevated Gastrointestinal 12-Hydroxylated Bile Acid Levels DOI Creative Commons
Keisuke Yoshikiyo, Hidehisa Shimizu, Edward G. Nagato

и другие.

Molecules, Год журнала: 2025, Номер 30(2), С. 281 - 281

Опубликована: Янв. 13, 2025

Our previous study demonstrated that γ-cyclodextrin (γ-CD)–perilla oil inclusion complexes increase plasma α-linolenic acid and eicosapentaenoic levels in healthy rats without adverse effects. The present examined the effects of perilla oil, γ-CD, their on fed cholic (CA) to mimic elevated gastrointestinal 12-hydroxylated (12OH) bile high-fat diet-fed rats. Rats CA (CA group) tended have higher AST, ALT, total cholesterol (T-CHO), triglyceride (TG) compared controls a standard diet CA. (CA+LP showed tendency for lower AST TG than those group. γ-CD (CA+CD had significantly T-CHO, controls, indicating severe liver injury dyslipidemia. γ-CD–perilla complex (CA+IC ALT CA+CD rats, with trend towards T-CHO levels. Plasma were CA+LP CA+IC groups groups. However, group This suggests an accelerated conversion group, which may contribute attenuation These findings suggest exacerbate dyslipidemia caused by 12OH levels, whereas ameliorate these altering fatty metabolism. Furthermore, we recommend evaluating safety both pathological models carefully selecting compounds co-ingested γ-CD.

Язык: Английский

Процитировано

0

Approaches for Inclusion Complexes of Ezetimibe with Cyclodextrins: Strategies for Solubility Enhancement and Interaction Analysis via Molecular Docking DOI Open Access

Dae-Yeong Cho,

Jeong-Gyun Lee,

Moon Jung Kim

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(4), С. 1686 - 1686

Опубликована: Фев. 16, 2025

This study aimed to improve the solubility of ezetimibe (EZT), which has low aqueous solubility, by preparing complexes using β-cyclodextrin (β-CD) derivatives. Phase studies and Job's plot confirmed a high apparent stability constant for EZT with β-CD even higher constants its derivatives, establishing 1:1 stoichiometric ratio. The composites were prepared spray drying over range molar ratios, their physicochemical properties evaluated techniques such as scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FT-IR). Saturation in vitro dissolution tests revealed that increased CD ratios. EZT/RM-β-CD inclusion (ICs) EZT/DM-β-CD ICs exhibited similar was greater than EZT/HP-β-CD EZT/SBE-β-CD (where RM, DM, HP, SEB represent H, CH3, -CH2-CHOH-CH3 -(CH2)4-SO3Na synthetic respectively). Most complexes, except at 1:2 or showed superior compared commercial products. Molecular docking simulations within CD, revealing hydrogen bonds binding energies aligned trends. These findings suggest derivatives significantly highlighting potential developing more effective oral solid formulations hyperlipidemia treatment.

Язык: Английский

Процитировано

0

Enhancing the Solubility of Isoconazole Nitrate Using Methyl-β-Cyclodextrin: Formulation and Characterization of Inclusion Complexes DOI Creative Commons
Tarek Alloush, Gülsel Yurtdaş Kırımlıoğlu

Molecules, Год журнала: 2025, Номер 30(8), С. 1654 - 1654

Опубликована: Апрель 8, 2025

Isoconazole nitrate (ISN) is a broad-spectrum antifungal agent whose therapeutic potential limited by poor aqueous solubility and low bioavailability. This study aimed to enhance the physicochemical properties of ISN through formation inclusion complexes with methyl-β-cyclodextrin (M-β-CD) using freeze-drying (FD) spray-drying (SD) methods. The prepared were comprehensively characterized high-performance liquid chromatography (HPLC), phase analysis, scanning electron microscopy (SEM), differential calorimetry (DSC), Fourier-transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (1H-NMR). Phase studies revealed an AL-type diagram 1:1 molar ratio apparent stability constant (KS) 2711 M−1. Structural thermal analyses confirmed successful complex reduced crystallinity. assessment showed that ISN/M-β-CD SD exhibited approximately seven-fold higher than performed better those FD. Moreover, demonstrated drug content. These findings highlight M-β-CD-based complexation, particularly via spray-drying, as effective strategy bioavailability poorly water-soluble drugs, such ISN.

Язык: Английский

Процитировано

0

Fabrication and Characterization of Co-Sensitized Dye Solar Cells Incorporating Cyclodextrin Functional Layers with Energy Transfer from Spiropyran Derivatives to Sq2-Dye DOI

Ryuhei Ejima,

Kanta Ono, Michihiro Hara

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Advancements in Cyclodextrin Complexes with Bioactive Secondary Metabolites and Their Pharmaceutical Applications DOI Creative Commons
Oana Elena Nicolaescu, Cătălina Ionescu, Adriana Samide

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(4), С. 506 - 506

Опубликована: Апрель 11, 2025

Cyclodextrins (CDs) have largely been investigated during the last decades for their outstanding properties, such as biocompatibility and biodegradability, with wide applications in pharmaceutical field, among which formation of inclusion complexes (ICs) natural or synthetic lipophilic compounds. This review prioritizes research recent years (2022–2025), being focused on (1) systematization ICs based structure secondary metabolite, namely (i) polyphenols (PPs), (ii) terpenes terpenoids (TTs), (iii) alkaloids (Alks); (2) each type complex, following aspects discussed: benefits complexation, composite materials, vitro/in vivo theoretical studies; (3) pharmacokinetics pharmacodynamics, risks, limitations, perspectives cyclodextrin metabolites.

Язык: Английский

Процитировано

0